Objective-Hydroxyapatite deposition on the medial layer of the aortic walls is the hallmark of vascular calcification and the most common complication in aging individuals and in patients with diabetes mellitus and those undergoing hemodialysis. Extracellular pyrophosphate is a potent physicochemical inhibitor of hydroxyapatite crystal formation. This study analyzed changes in extracellular pyrophosphate metabolism during the phosphate-induced calcification process. Approach and Results-Phosphate-induced calcification of ex vivo-cultured aortic rings resulted in calcium accumulation after 7 days. This accumulation was enhanced when aortic walls were devitalized. BMP2 (bone morphogenic protein 2) expression was associated with calcium accumulation in cultured aortic rings, as well as in cultured vascular smooth muscle cells (VSMCs) and in calcitriol-induced calcification in rats. Hydroxyapatite dose dependently induced BMP2 overexpression in VSMCs. Moreover, TNAP (tissue nonspecific alkaline phosphatase) mRNA levels and activity were found to be downregulated in early phases and upregulated in later phases of calcification in all 3 models studied. eNPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1) increased from early to later phases of calcification, whereas eNTPD1 (ectonucleoside triphosphate diphosphohydrolase 1) was downregulated during later phases. Synthesis of pyrophosphate in VSMCs increased significantly over time, in all 3 models studied. Because the rate of pyrophosphate hydrolysis was 10× slower than the rate of pyrophosphate synthesis, pyrophosphate synthesis is determined mainly by the ratio of eNPP1 to eNTPD1 activity. Hydroxyapatite also induces increments both in TNAP and eNPP1/eNTPD1 ratio in VSMCs. Conclusions-Pyrophosphate synthesis increases in VSMCs during phosphate-induced calcification because of compensatory regulation of extracellular pyrophosphate metabolism. Visual Overview-An online visual overview is available for this article.
V ascular calcification-the most common complication in aging individuals and in patients with diabetes mellitus and those undergoing hemodialysis-has been associated with cardiovascular events and all-cause mortality. 1 Accumulation of calcium-phosphate crystals, mainly hydroxyapatite, in the medial layer of the aortic walls is the hallmark of vascular calcification. Hyperphosphatemia has been associated with vascular calcification, 2-4 due probably to increases in the spontaneous formation of calcium-phosphate crystals. 5, 6 Phosphate-induced calcification also induces osteochondrogenic phenotypic changes in cultured vascular smooth muscle cells (VSMCs), including the upregulation of BMP2 (bone morphogenic protein 2) and the downregulation of the SM22α (adult smooth muscle marker 22α). 7, 8 Extracellular pyrophosphate is a potent physicochemical inhibitor of hydroxyapatite crystal formation and growth in vitro 9 and in vivo. [10] [11] [12] [13] Reductions in plasma pyrophosphate concentrations have been associated with vascular calcification in hemodialysis patients. 14 Pyrophosphate is generated enzymatically by hydrolysis of extracellular ATP by the enzyme eNPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1). 15, 16 Moreover, most pyrophosphate is degraded to Pi by TNAP (tissue nonspecific alkaline phosphatase) in the aortic wall, and TNAP overexpression in VSMCs is sufficient for ex vivo calcification of aortic rings. 17 Extracellular ATP, as well as ADP, is also hydrolyzed by the enzyme eNTPD1 (ectonucleoside triphosphate diphosphohydrolase 1), releasing phosphate. By reducing the availability of extracellular ATP to generate pyrophosphate, eNTPD1 may be involved in vascular calcification. 10 This study analyzed changes in the enzymes involved in extracellular pyrophosphate metabolism during phosphateinduced calcification using 3 experimental models, including vitamin D rats and cultured VSMCs and aortic rings.
Materials and Methods
The data that support the findings of this study are available from the corresponding author on reasonable request.
Animals
Male Sprague-Dawley rats (8) (9) (10) (11) (12) 
Aorta Isolation and Calcification Assay
Rats were euthanized via carbon dioxide inhalation, and thoracic aorta tissue was perfused with saline and removed according to previously published protocols. 17, 18 For calcification assays, aortic rings were cultured ex vivo (37°C, 5% CO 2 ) in Minimum Essential Medium (MEM) Eagle (Gibco, Paisley, United Kingdom) containing 45-calcium as a radiotracer (Perkin Elmer, Boston), 1 mmol/L L-glutamine, 100 IU/ mL, penicilin, 100 μg/mL streptomycin, and 0.1% fetal bovine serum. For calcification assays, aortic rings were cultured in MEM media supplemented with phosphate (KH 2 PO 4 /K 2 HPO 4 pH 7.4) at a final concentration of 2 mmol/L phosphate (1 mmol/L in control). After 7 days of incubation (Figure 1 ), or the indicated time in Figure 3 , aortic rings were dried, and radioactivity was measured via liquid scintillation counting (Perkin Elmer Tri-Carb 2810TR).
Devitalized aortas were obtained by freezing at −80°C for 6 months. After that, aortas were washed 5× in distillated water.
For analytic parameters, shown in Figure 5 , blood samples were collected in heparinized tubes from euthanized rats, centrifuged to obtain plasma, and analyzed using an ADVIA CENTAUR 2400 autoanalyzer, following the manufacturer's protocols. Pyrophosphate was measured using an enzyme-linked bioluminescence assay, as described previously.
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Aortic Staining
Rat aortas were included in an optimal cutting temperature compound (Sakura, Alphemaan den Rijn, The Netherlands), and 5-μm cross sections were cut using a cryostat (Leica CM1940). Calcification of aortic tissue was revealed by Alizarin Red and Von Kossa staining. Cell content and tissue architecture were revealed by Trichrome, van Gieson, and hematosine and eosin staining.
Pyrophosphate Metabolism
For pyrophosphate/ATP hydrolysis experiments ( Figure 1D and 1E) , medial layer of aortic rings (or VSMCs) was incubated ex vivo in Hanks balanced salt solution (BE10-527F; Lonza) containing the indicated amount of pyrophosphate or ATP and 32 PPi (32-pyrophosphate) or [γ 32 P]ATP (PerkinElmer) as a radiotracer, respectively. After the indicated time of incubation, ortophosphate was separated from ATP and pyrophosphate, as described previously. 17 Briefly, 20 μL of sample was mixed with 400 μL of ammonium molybdate (to bind the orthophosphate, 09913; Sigma-Aldrich) and 0.75 mol/L sulfuric acid (258105; Sigma-Aldrich). Samples were then extracted with 800 μL of isobutanol/petroleum ether (4:1) to separate the phosphomolybdate from the pyrophosphate and ATP (catalog number 77379 and 360465 for petroleum ether and isopropanol, respectively; Sigma-Aldrich). Next, 400 μL of the organic phase containing phosphomolybdate was removed and subjected to radioactivity counting. The same aortic rings were used for both ATP and pyrophosphate hydrolysis assays. After ATP hydrolysis, assay rings were washed 5× in Hanks balanced salt solution before performing the pyrophosphate hydrolysis assay.
To analyze the products released during ATP hydrolysis, medial layers of aortic rings were incubated in Hanks balanced salt solution containing ATP and [γ 32 P]ATP at a final concentration of 1 μmol/L and 10 μCi/mL, respectively. After the indicated time (as shown in the figures), production of 32 Pi (32-phosphate) and 32 PPi was determined using chromatography on PEI cellulose plates (50488-25EA-F; Sigma-Aldrich) developed with 650 mmol/L K 2 HPO 4 (P5655; Sigma-Aldrich) pH3, as described previously. 17 After radiography, spots were excised and counted by liquid scintillation (UltraGold, 6013329; Perkin Elmer).
To remove adventitia layer, aortas were digested for 10 minutes with collagenase, as described previously. 19 Then, the ATP hydrolysis assay was performed. After washing 5× in Hanks balanced salt solution media, the same aortic rings were used for pyrophosphate hydrolysis assay. Finally, the aortic rings were dried and weighed.
Cultured Cells and Calcification Assays
VSMCs were obtained from rat thoracic aortas by double digestion using the collagenase method, as described previously. 19 Cells were grown in MEM media, which contained 1 mmol/L L-glutamine, 100 IU/mL penicilin, 100 μg/mL streptomycin, and 10% fetal bovine serum at 37°C in a humidified atmosphere of 5% CO 2 . Cells were grown to confluence and used after an overnight quiescence step (0.1% fetal bovine serum). Calcification assays were performed on cells incubated for 7 days in MEM media supplemented with 0.1% fetal bovine serum and 2 mmol/L phosphate, as described previously. 5 To quantify the calcium content of VSMCs, wells were treated with 0.6 mol/L HCl overnight at 4°C and analyzed using a colorimetric QuantiChrom calcium assay kit (BioAssay Systems, Hayward, CA). 
Real-Time Polymerase Chain Reaction
Total RNA was isolated by TRIzol extraction (Invitrogen), and cDNA was generated using the Superscript III cDNA synthesis system (Invitrogen) according to the manufacturer's instructions. The relative quantification of rat BMP2, SM22α, TNAP, eNTPD1, and eNPP1 was performed using real-time polymerase chain reaction using SYRB Green, following the manufacturer's instruction. The primers used for amplification were BMP2: 5′-GTTCTGTCCCTACTGATGAG-3′ (forward) and 5′-ATTCGGTGCTGGAAACTAC -3′(reverse); SM22α: 5′-CAGAC TGTTGACCTCTTTGAAG-3′ (forward) and 5′-TCTTATGCTC CTGGGCTTTC-3′ (reverse); TNAP: 5′-TGAATCGGAACAACCT GACTG-3′ (forward) and 5′-GCCTCCTTCCACTAGCAAGA A-3′ (reverse); eNTPD1: 5′-CAGGTTTCAAGTGGTGGGATT-3′ (forward) and 5′-GAAGGCACACTGGGAGTAAGG-3′ (reverse); and eNPP1: 5′-AAGGTATGCCCAAGAAAGGAA-3′ (forward) and 5′-TTCTTGACTGCGGATGACTCT-3′ (reverse The primers used for its amplification were 5′-CACCTTCCCACTGGCTGAA-3′
(forward) and 5′-CACCTTCCCACTGGCTGAA-3′(reverse). The primers used for amplification in human cells are summarized in Methods in the online-only Data Supplement.
Kinetic Analysis
Pyrophosphate and the ATP saturation kinetics for its hydrolysis, were fitted to a Michaelis-Menten equation using nonlinear regression, V=V max S/(K m +S), where V is the velocity of pyrophosphate/ ATP hydrolysis, V max is the maximal velocity or capacity of pNPP hydrolysis, S is the concentration of pyrophosphate/ATP, and K m is the affinity constant. 18 The mean activation concentration (AC 50 ) or mean inhibitor concentration (IC 50 ) was calculated by nonlinear regression using the 1-site competition equation, V=bottom+(
]), where top refers to the maximal expression in the absence of an activator (hydroxiapatite), and bottom refers to no activation.
Statistical Analysis
Results are presented as mean±SEM. The Kolmogorov-Smirnov test was used to assess the normality of the data. Student t test or 1-way ANOVA and Tukey multiple comparison post hoc test were used for statistical analyses (according to figure legends). Statistical significance was determined using GraphPad Prism 5 software.
Results
Characterization of Vascular Calcification in Cultured Aortic Rings Ex Vivo
Thoracic aortas excised from rats and frozen at −80°C for at least 6 months were thawed and washed 5× in distilled water to obtain devitalized aortas. In addition, thoracic aortas extracted from rats were immediately washed in MEM media to obtain normal aortas. Both devitalized and normal aortas were cut into rings, with each aorta yielding 4 rings. To confirm that devitalized aortas had lost cellular activity, some rings were fixed in optimal cutting temperature, sectioned, and stained for histological examination. Hematoxylin and eosin staining showed that, compared with normal aortas, devitalized aortas had lost cells, whereas both trichrome and van Gieson staining showed that tissue architecture was the same in both normal and devitalized aortas ( Figure 1A ).
Both types of rings were subsequently cultured ex vivo in MEM medium supplemented with 2 mmol/L phosphate and 45-calcium as a radiotracer, with the medium replaced daily. After 7 days, the aortic rings were dried, and the accumulated 45-calcium was quantified by liquid scintillation counting. Accumulation of 45-calcium was lower in normal than in devitalized aortic rings (118.9 µmol Ca 2+ per g versus 433 µmol Ca 2+ per g; Figure 1B ). Moreover, the addition of 100 µmol/L levamisole, which inhibits TNAP, had no effect on the accumulation of 45-calcium in both aortic ring types. The addition of 100 µmol/L pyrophosphate, which inhibits calcification, significantly reduced 45-calcium accumulation by both aortic ring types. Interestingly, staining with Alizarin Red and von Kossa stains, which indicate calcification, failed to detect phosphate-calcium crystals ( Figure 1B ). These findings indicate that 45-calcium accumulation increases in the presence of calcium and phosphate in a dose-dependent manner ( Figure 1C) . Finally, the addition of PSB069-an inhibitor of eNTPD activitysignificantly reduced 45-calcium accumulation by normal aortic rings ( Figure IA in the online-only Data Supplement). In contrast, the addition of pyrophosphatase, which hydrolyzes pyrophosphate to phosphate, significantly increased 45-calcium accumulation by normal aortic rings. Moreover, siRNA knowkdown of eNPP1 significantly increased 45-calcium accumulation by normal aortic rings ( Figure IB in the online-only Data Supplement).
Incubation of normal aortic rings in MEM medium containing 1 mmol/L phosphate for 7 days resulted in pyrophosphate hydrolysis over time (1.54±0.17 pmol×mg ; Figure 1D , top). However, the rate of pyrophosphate hydrolysis was 10-fold lower in devitalized aortic rings (0.17±0.02 pmol×mg
). The addition of 100 µmol/L levamisole to normal aortic rings significantly (P<0.001) reduced the rate of pyrophosphate hydrolysis to 43.1% ( Figure 1D , bottom, left) but had no effect on residual pyrophosphate hydrolysis in devitalized aortic rings ( Figure 1D 
Phosphate-Induced Calcification in Cultured Aortic Rings
Normal aortic rings were incubated for 1, 2, or 3 weeks in MEM containing 1 or 2 mmol/L phosphate. Alizarin Red staining of histological sections showed significant accumulation of calcium after 3 weeks of incubation with 2 mmol/L phosphate ( Figure IIIA in the online-only Data Supplement). However, calcium accumulation after 1 week was significantly higher (118.79±30.9 versus 6.37±1.4 µmol Ca 2+ per g of aorta; P<0.001) when calcium was measured as 45-calcium accumulation ( Figure IIIB in the online-only Data Supplement, top). BMP2 mRNA levels in normal aortic rings were significantly increased after 2 (P<0.05) and 3 (P<0.001) weeks of incubation in MEM containing 2 mmol/L phosphate ( Figure  IIIB in the online-only Data Supplement, bottom). eNPP1 was also significantly increased after 1, 2, and 3 weeks of incubation with respect to the control (Figure 2A ), whereas eNTPD1 mRNA showed a significant reduction only after 3 weeks. Although TNAP mRNA levels were significantly reduced after 1 (P<0.001; 2.9-fold) and 2 weeks (P<0.001; 1.8-fold), they showed a slight but significant increase after 3 weeks (P<0.001; 1.3-fold). Hematoxylin and eosin and trichrome staining of aortic ring sections incubated for 1, 2, and 3 weeks with MEM containing 1 or 2 mmol/L phosphate showed no loss of cells or tissue architecture ( Figure 2B ).
Phosphate-Induced Calcification in Cultured VSMCs
Rat VSMCs were incubated for 1, 3, and 5 days in MEM containing 1 or 2 mmol/L phosphate. Quantification of calcium deposition showed significant increases in deposited calcium after incubation for 3 (2-fold) and 5 (6-fold) days with 2 mmol/L phosphate ( Figure 3A) . Levels of BMP2 mRNA ( Figure 3B ) and eNPP1 mRNA were significantly increased after 3 and 5 days ( Figure 3C ), whereas levels of eNTPD1 mRNA decreased after 3 and 5 days. TNAP mRNA levels significantly decreased after 1 day but significantly increased Finally, the addition of 100 µmol/L levamisole had no significant effect on the calcium accumulation in rat VSMCs ( Figure V in the online-only Data Supplement). Moreover, the addition of 100 µmol/L pyrophosphate, which inhibits calcification, significantly reduced calcium accumulation by VSMCs.
Calcitriol-Induced Calcification in Rats
Rats injected intraperitoneally with calcitriol (1 µg·kg
showed calcification in the middle of the medial layer of the aortic wall after 3 days ( Figure 4A ). However, Alizarin Red and von Kossa staining showed the absence of calcification after 1 day of treatment with calcitriol. The presence of calcium-phosphate crystals in the aortic wall was associated with increases in BMP2 mRNA levels ( Figure 4B ). Moreover, TNAP mRNA in the medial layer was downregulated progressively after 1 (0.7-fold) and 3 (0.1-fold) days. Levels of eNTPD1 mRNA were significantly reduced only after 3 days, whereas levels of eNPP1 mRNA increased significantly after 1 (1.4-fold) and 3 (1.5-fold) days ( Figure 4C ). Plasma phosphate (12.7 versus 10.7 mg/dL) and calcium (16.04 versus 12.9 mg/dL) concentrations were significantly higher after 3 days of calcitriol treatment than in untreated rats ( Figure 4D ). Alkaline phosphatase activity in heparinized plasma was significantly lower after treatment with calcitriol for 1 (104 U/L) and 3 (162 U/L) days than in control rats (200.5 U/L). Pyrophosphate concentration was also significantly lower than in the control after 3 days of calcitriol treatment (1.2 versus 2 µmol/L), resulting in a significant reduction in pyrophosphate/ phosphate ratio. 
Pyrophosphate Production by VSMCs During Calcification
The level of eNTPD1 mRNA in the medial layer of extracted aortic rings, or those cultured ex vivo for 1 week, was 9-and 11-fold higher than the levels of eNPP1 and TNAP mRNAs, respectively ( Figure 4A ). By contrast, although the level of eNPP1 mRNA was 10-fold higher than that of TNAP mRNA in VSMCs, the levels of eNPP1 and eNTPD1 mRNAs were similar. All 3 models showed that 1 µmol/L ATP was completely hydrolyzed after 45 minutes ( Figure 5B ). Thin layer chromatography of the hydrolysis products of [γ 32 P]ATP in the extracted and cultured medial aortic rings showed that 9% and 8%, respectively, of the released product was 32 PPi (32-pyrophosphate), whereas 43% of the released product was 32 PPi in VSMCs. The addition of 100 µmol/L levamisole during ATP hydrolysis did not significantly increase the release of pyrophosphate, whereas the addition of PPi during ATP hydrolysis markedly reduced the release of 32 PPi ( Figure 5C ). Interestingly, pyrophosphate synthesis was increased in all models ( Figure 6 ). Phosphate-induced calcification of rat VSMCs significantly increased pyrophosphate synthesis after 1, 3, and 5 days, and phosphate-induced calcification of medial aortic rings cultured ex vivo significantly increased pyrophosphate synthesis after 1, 2, and 3 weeks. Calcitriol-induced calcification in rats also significantly increased pyrophosphate synthesis in medial aortic rings after 1 and 3 days. Similar results were obtained in human VSMCs ( Figure IVC 
Hydroxyapatite Induces Overexpression in Both TNAP and eNPP1/eNTPD1 Ratio in VSMCs
Incubation of VSMCs in MEM containing 100 µg/mL hydroxyapatite significantly increased both TNAP and eNPP1 mRNA levels and significantly reduced eNTPD1 mRNA levels ( Figure VI in the online-only Data Supplement). Hydrolysis of 32 PPi (32-pyrophosphate) showed that TNAP activity had increased. Moreover, incubation of VSMCs with hydroxyapatite for 24 hours increased 32 PPi release via [γ 32 P] ATP hydrolysis.
Discussion
Hyperphosphatemia is an important risk factor for vascular calcification. [2] [3] [4] Increases in plasma phosphate concentrations induce the formation and deposition of calcium-phosphate crystals, mainly hydroxyapatite, on elastin/collagen fibers. 5, 20 This study showed that phosphate-induced calcification of aortic rings ex vivo increased the accumulation of 45-calcium, although crystal deposition was not observed during the early stages of this process. Although Alizarin Red and von Kossa stains detected calcium-phosphate crystals of adequate minimum size, these stains were unable to detect microcalcifications, suggesting that these stains are inadequate in assaying early stages of calcification. By contrast, measurement of 45-calcium is effective in quantifying the degree of calciumphosphate crystal formation and accumulation in early stages of calcification.
Changes in the mRNA expression profile of VSMCs have been observed during the calcification process. 1 For example, phosphate-induced calcification was found to increase BMP2 mRNA levels while reducing SM22α. 1 Similarly, we found that hydroxyapatite induced the overexpression of BMP2 mRNA directly in a dose-dependent manner, suggesting that the expression of BMP2 during phosphate-induced calcification is in response to the accumulation of hydroxyapatitethe main phosphate-calcium crystal found in calcified soft tissue. Using as models of phosphate-induced calcification Figure 4 . Calcitriol-induced calcification in rats. Aortic ring derivates from rats that were intraperitoneally injected with 1 μg of calcitriol per kg for 1 or 3 d. A, Representative images (original ×20 magnification) of the indicated staining performed on aortic ring sections. B, BMP2 (bone morphogenic protein 2) mRNA levels. C, eNTPD1 (ectonucleoside triphosphate diphosphohydrolase 1), eNPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1), and TNAP (tissue nonspecific alkaline phosphatase) mRNA levels. D, Biochemical parameters in plasma samples, including inorganic phosphate (Pi) and inorganic pyrophosphate (PPi). One-way ANOVA and Tukey multiple comparison post hoc test were used for statistical analysis (n=11 rats, in 3 independent experiments). *P<0.05, **P<0.01, ***P<0.001.
aortic rings cultured ex vivo and VSMCs cultured in vitro, we found that BMP2 expression increased when sufficient calcium accumulated. Therefore, although histopathologic staining was unable to detect crystal accumulation during early stages of calcification, BMP2 mRNA overexpression may be a marker of calcium accumulation, as previous studies have shown. 5, 10 Pyrophosphate in extracellular fluids is a potent endogenous inhibitor of hydroxyapatite formation and growth. [10] [11] [12] [13] Pyrophosphate is extracellularly produced by eNPP1 hydrolysis of ATP 15 and is degraded by TNAP to Pi 10,17 ( Figure 7 ). The present study found a compensatory response of eNPP1 and TNAP during early phases of both calcitriol-induced and phosphate-induced calcification. For example, phosphate-induced calcification in aortic rings cultured ex vivo for 1 week downregulated TNAP mRNA and enzymatic activity, whereas upregulated eNPP1 mRNA and activity. These changes were also found after 1 day during phosphate-induced calcification of cultured VSMCs and during calcitriol-induced calcification in vivo. In all of these model systems, BMP2 was not overexpressed during early stages of calcification, indicating an absence of calcium accumulation, but the synthesis of pyrophosphate was significantly increased.
This study also indicated a new model for assessing calcification. Although calcitriol-induced calcification for 3 days resulted in localized crystals in the middle of the medial layer of the aortic wall, phosphate-induced calcification of cultured aortic rings showed crystal accumulation throughout the entire medial layer. In addition, aortic rings cultured ex vivo accumulated calcium-phosphate crystals more effectively when cellular activity was lost, as in devitalized aortas. This finding confirms results showing a greater degree of in vitro calcification when VSMCs were fixed, 5 suggesting that calcium-phosphate deposition is a physicochemical process independent of cellular activity. 21 Moreover, the present study also supports the hypothesis that cellular activity plays a key role in the synthesis of pyrophosphate and other calcification inhibitors. 9, 21, 22 TNAP has been described as a marker of phosphateinduced calcification because it is upregulated in calcified tissues. 1 The present study also found that TNAP was upregulated in phosphate-induced models of calcification accompanied by upregulation of BMP2 and accumulation of calcium-phosphate crystals. For example, phosphate-induced calcification increased the expression and activity of TNAP in cultured VSMCs after 3 and 5 days, as well as increasing calcium accumulation and BMP2 expression. These same Figure 6 . Pyrophosphate hydrolysis and production in vascular smooth muscle cells (VSMCs) increases during calcification. A, 32 PPi (32-pyrophopshate) produced by hydrolysis of 1 μmol/L of ATP (10 μCi/mL [γ 32 P]ATP as a radiotracer). B, 32 PPi hydrolysis of 1 μmol/L of inorganic pyrophosphate (PPi; 10 μCi/ mL 32 PPi as a radiotracer). One-way ANOVA and Tukey multiple comparison post hoc test were used for statistical analysis. n=11 rats (in vivo), n=12 rings (ex vivo), and n=9 (in vitro; 3 independent experiments with 3 well per experiment). *P<0.05, **P<0.01, ***P<0.001. changes were observed during phosphate-induced calcification of cultured aortic rings for 2 and 3 weeks. Moreover, TNAP was upregulated when VSMCs were incubated with hydroxyapatite for 1 day. All of these findings suggest a compensatory downregulation of TNAP in response to high phosphate levels during early phases of phosphate-induced calcification but TNAP upregulation in response to calciumphosphate deposition during late phases of calcification. These findings may explain the apparent contradictions observed during VSMC calcification, 23 in that TNAP expression was reported to be upregulated 24 and downregulated 25 . Although TNAP was shown to be upregulated during early phases in 5 of 6 nephrectomized rats, 26 this upregulation, in the absence of calcium accumulation, may be in response to inflammatory cytokines, such as tumor necrosis factor-α and interleukin 6, which enhance the mineralization associated with increases in TNAP expression. 27 Indeed, TNAP activity was increased in VSMCs cocultured with proinflammatory M1 macrophages, 28 and TNAP was found to be upregulated in the aortic walls of uremic rats. 24 The contribution of TNAP to extracellular pyrophosphate metabolism may be relative. For example, we showed that, in rat aortic wall, the rate of ATP hydrolysis (V max and K m of 6177 pmol×g . 18 Similarly, in the present study, using cultured aortic rings incubated for 1 week, found that the V max values for pyrophosphate and ATP hydrolysis were 56.7 and 5016 pmol×g −1 ×min −1
, respectively. Moreover, the levels of expression of eNTPD1 mRNA, both in extracted and cultured aortic rings, were 10-fold higher than those of eNPP1 and TNAP mRNAs. These findings indicate that 32 PPi production via the hydrolysis of [γ 32 P]ATP is <10% of the ATP hydrolyzed, with >90% of ATP used for 32 Pi synthesis. This finding suggests that eNTPD activity (ATP→phosphate) is greater than eNPP activity (ATP→pyrophosphate) in the medial layer of cultured aortic rings. This study also found that inhibiting TNAP activity during ATP hydrolysis did not alter the amount of pyrophosphate produced. However, the levels of eNPP1 and eNTPD1 expression were similar in VSMCs, suggesting that 50% of ATP is hydrolyzed to pyrophosphate. This differential eNPP1/TNAP/eNTPD expression profile could be dependent on the methods used for VSMC extraction and culture.
TNAP is altered in different ways during the process of phosphate-induced calcification, although pyrophosphate production increased over time in all 3 model systems ( Figure 6A) . Moreover, the ratios of eNPP1/eNTPD1 expression and activity largely determine pyrophosphate production. For example, increases in eNPP1 expression during the calcification process induce greater increases in pyrophosphate synthesis than the presence or absence of TNAP activity. In addition, pyrophosphate synthesis was enhanced when eNTPD1 was downregulated during late stages of calcification, accompanied by a higher eNPP1/eNTPD1 ratio. Therefore, analysis of pyrophosphate synthesis and hydrolysis in individual tissues should include measures of both the eNPP/eNTPD ratio and TNAP.
Systemic pyrophosphate may play a predominant role in preventing vascular calcification 29 -a process enhanced by upregulation of TNAP activity in the aortic wall. 24 This finding was also observed in a mouse model of progeria-a condition characterized by vascular calcification, in which both systemic and aortic pyrophosphate synthesis was impaired. 10 Therefore, systemic pyrophosphate concentration may play a key role in preventing calcification. 14 We found that, after 3 days of calcitriol treatment, plasma pyrophosphate concentrations were reduced, whereas plasma phosphate concentrations were increased, in rats with calcium-phosphate crystals in the aortic wall. This resulted in a reduction in the systemic pyrophosphate/ phosphate ratio, 22 which plays a critical role in the calcification process. [30] [31] [32] [33] This effect of systemic inhibitors on the calcification of smooth muscle cells cannot be assessed using in vitro and ex vivo models, with this being the main limitation of this study.
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